about
Long-term outcome in medical patients aged 80 or over following admission to an intensive care unit.Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study.Fluid management in acute lung injury and ards.Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial.Lung ultrasonography for assessment of oxygenation response to prone position ventilation in ARDS.Fatal Septic Shock Triggered by Donor Transmitted Varicella Zoster Virus Reinfection 3 Days After Lung Transplantation.How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study.Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.Cytomegalovirus reactivation enhances the virulence of Staphylococcus aureus pneumonia in a mouse model.Point-of-care ultrasound in intensive care units: assessment of 1073 procedures in a multicentric, prospective, observational study.Night shift decreases cognitive performance of ICU physicians.Respiratory rate and peak inspiratory pressure, new targets from the LUNG SAFE study analysis or physiopathological artifacts?Haemophilus parahaemolyticus septic shock after aspiration pneumonia, France.Does admission during morning rounds increase the mortality of patients in the medical ICU?Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center.Cytomegalovirus reactivation enhances the virulence of a staphylococcus aureus pneumonia in a mouse model.Venovenous extracorporeal membrane oxygenation devices-related colonisations and infections.Extra vascular lung water but not lung ultrasound predicts grade 3 pulmonary graft dysfunction and utilization of rescue therapies for severe hypoxemia after lung transplantation.Early application of airway pressure release ventilation in acute respiratory distress syndrome: a therapy for all?Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.Adding ketamine to morphine for patient-controlled analgesia after thoracic surgery: influence on morphine consumption, respiratory function, and nocturnal desaturation.Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients.Prone positioning during veno-venous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome in adults.Transforming Growth Factor-β1 in predicting early lung fibroproliferation in patients with acute respiratory distress syndromeExtracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress SyndromeAcute respiratory distress syndrome phenotyping and latent class analysis, first steps toward precision medicine in critical care illness?Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome[Influence of the analgesic strategy on the respiratory function after thoracic surgery for lobectomy]Right ventricular function during high-frequency oscillatory ventilation in adults with acute respiratory distress syndromeSignificance of high levels of procalcitonin in patients with influenza A (H1N1) pneumoniaPulmonary capillary blood flow and cardiac output measurement by partial carbon dioxide rebreathing in patients with acute respiratory distress syndrome receiving lung protective ventilationA strategy based on galactomannan antigen detection and PCR for invasive pulmonary aspergillosis following influenza A (H1N1) pneumoniaExtracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: a prospective observational comparative study[Ischemic cholangitis in intensive care unit: favourable outcome with ursodesoxycholic acid and fenofibrate]Non-ventilatory therapies for acute respiratory distress syndromeImpact of education and training course for ECMO patients based on high-fidelity simulation: a pilot study dedicated to ICU nursesExtracorporeal membrane oxygenation in acute respiratory distress syndrome: why is the EOLIA trial important?Variability of reverse triggering in deeply sedated ARDS patientsProne positioning and extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: time for a randomized trial?Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort
P50
Q35567288-9AA80E3F-2978-4EF5-8C9D-3F0B9CA3EB88Q35908246-9AE9F3EE-D82D-400D-BDC2-D63508C50115Q37929888-CD9B44F8-D0A3-4584-B421-6FAC630F7366Q38443294-893E19A6-7ECD-42FE-B368-3663CC147050Q39669326-0DE1BD1B-661F-46F9-AB27-DFAB5789DA4FQ40105897-5D27385A-D2C2-42C1-94FB-859DDC523418Q40108722-346DDB31-E5F3-4D3D-8130-F366EE12D6B8Q40396174-DE27C399-0043-494C-A686-7910FDFE43ADQ40512606-0ACCEEE3-6244-4BBA-9E99-D14C5975CE74Q40752180-2D20C172-075F-43A7-8AE1-6029D8700EACQ40914813-624C01FA-3917-4245-B874-560DD9611FE2Q42318802-BAE908FB-8686-45AA-A75E-AD22FB0D84FDQ42931186-664B85CF-B7F8-498F-A974-2B6623657AF5Q43633973-D13CDE1D-E2B2-4D53-B73F-466CE9E2AD04Q43895106-AAF1C097-7293-43A4-940D-9E18162BA9C0Q46091549-A13867CD-9B12-48F5-B90A-4CD868AA3F32Q47110844-022AF168-B36D-4E58-8C14-F16B80010805Q47130667-EDC02052-68E3-4A3D-84C1-B933822F185FQ47715987-5C34BF9A-2C21-4419-AD9D-BC39E2705F91Q47969209-76734E35-D3B4-496A-8BF8-86976E3193A1Q48589714-F2870082-9E89-45D0-8C02-B5330C9CAFB5Q51834069-E358FBB0-3FD4-4604-ABDF-2E5CCE61627FQ54565347-567626BB-84FE-4021-A0B9-6C0713F10DF5Q58612008-16D37A1B-37A1-4C3C-BC47-CE1D8411911FQ60222603-87DFECFD-05DB-41CD-942D-76EA1210B76DQ64081347-08EE25F8-70D0-4D85-80C8-3CCA606F42E5Q64110120-8CD79E30-A1BF-46AA-BB42-6E8334F0000DQ79869859-D7D5C4B5-1B04-4947-B936-F1AFD4EB7B50Q83914633-F3E55D95-31B9-4F4D-B901-E807ECA889D3Q84616672-3CF30692-E97B-49A5-9E91-EEC83E49F3B3Q84650898-7D91DD73-6770-4E6B-9C19-97476FF4E327Q84730931-1643E773-CE5C-4868-AB2C-00D739C2EC94Q84767422-F760CB9B-BC32-41DC-99CC-BDC056CE61C8Q85584029-56A2C1BA-80DA-4FCE-88A2-C7F929C9D1D8Q88624771-6223C197-BCE6-4BC0-812F-C68A416FB371Q90268905-2E4A9B70-FE43-4929-AB81-A7CF7107AB9FQ90911505-7618053D-9747-4A51-ACF9-BC8C39905B1DQ92026895-939D9DA6-8A03-4B1E-A060-339B4C8C52B3Q92135809-D1E06E63-FA43-4928-A2AB-A733BD7C9D7AQ92398800-EE610581-1BBB-4A9F-9264-4B8E165B3B0C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Christophe Guervilly
@en
Guervilly C
@nl
type
label
Christophe Guervilly
@en
Guervilly C
@nl
altLabel
Guervilly C
@en
prefLabel
Christophe Guervilly
@en
Guervilly C
@nl
P31
P496
0000-0001-9066-6591